Vivos Therapeutics, Inc. Common Stock (VVOS) Stock Price

VVOSStock

$0.27−93.41%52W

Market Cap$5.34M

P/E—

PEG Ratio—

Div yield—

Beta6.24

VVOS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-94.16%

Price vs S&P 500 (4W)-37.15%

VGM Score56.95

Book Value / Share (Quarterly)$0.31

P/TBV (Annual)3.33x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.88%

Cash Flow / Share (Quarterly)$-1.46

Price vs S&P 500 (YTD)-98.32%

Gross Margin (TTM)61.80%

Net Profit Margin (TTM)-127.70%

EPS (TTM)$-2.12

10-Day Avg Trading Volume1.17M

EPS Excl Extra (TTM)$-2.12

Revenue Growth (5Y)5.94%

EPS (Annual)$-2.06

ROI (Annual)-140.01%

Gross Margin (Annual)60.44%

Net Profit Margin (5Y Avg)-112.58%

Cash / Share (Quarterly)$0.16

Revenue Growth QoQ (YoY)70.46%

ROA (Last FY)-84.17%

Revenue Growth TTM (YoY)33.77%

EBITD / Share (TTM)$-1.78

ROE (5Y Avg)-818.50%

Operating Margin (TTM)-115.47%

Cash Flow / Share (Annual)$-1.90

P/B Ratio1.57x

P/B Ratio (Quarterly)10.12x

Net Income / Employee (Annual)$-79,000

EV / Revenue (TTM)0.50x

Net Interest Coverage (TTM)-14.16x

ROA (TTM)-98.12%

EPS Incl Extra (Annual)$-2.06

Current Ratio (Annual)0.24x

Quick Ratio (Quarterly)0.22x

3-Month Avg Trading Volume1.82M

52-Week Price Return-93.41%

Revenue / Employee (TTM)$73,000

Tangible BV / Share (Quarterly)$0.04

P/S Ratio (Annual)0.23x

Asset Turnover (Annual)0.69x

52-Week High$5.12

Operating Margin (5Y Avg)-116.51%

EPS Excl Extra (Annual)$-2.06

CapEx CAGR (5Y)81.15%

26-Week Price Return-82.91%

Quick Ratio (Annual)0.20x

13-Week Price Return-52.67%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.27x

Enterprise Value$9.73M

Revenue / Share Growth (5Y)-37.57%

Asset Turnover (TTM)0.77x

Revenue / Employee (Annual)$65,100

Pretax Margin (Annual)-121.71%

Cash / Share (Annual)$0.22

3-Month Return Std Dev124.39%

Gross Margin (5Y Avg)63.50%

Net Income / Employee (TTM)$-93,200

ROE (Last FY)-140.01%

Net Interest Coverage (Annual)-11.40x

EPS Basic Excl Extra (Annual)$-2.06

Receivables Turnover (TTM)15.74x

Total Debt / Equity (Quarterly)3.51x

EPS Incl Extra (TTM)$-2.12

Receivables Turnover (Annual)17.35x

ROI (TTM)-187.51%

P/S Ratio (TTM)0.20x

Pretax Margin (5Y Avg)-112.65%

Revenue / Share (Annual)$1.70

Tangible BV / Share (Annual)$1.29

Price vs S&P 500 (52W)-111.72%

Year-to-Date Return-86.36%

5-Day Price Return-5.91%

EPS Normalized (Annual)$-2.06

ROA (5Y Avg)-103.54%

Net Profit Margin (Annual)-121.37%

Month-to-Date Return-32.49%

Cash Flow / Share (TTM)$-13.48

EBITD / Share (Annual)$-1.81

Operating Margin (Annual)-114.05%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-816.53%

LT Debt / Equity (Quarterly)3.31x

EPS Basic Excl Extra (TTM)$-2.12

P/TBV (Quarterly)71.19x

P/B Ratio (Annual)3.18x

Pretax Margin (TTM)-128.36%

Book Value / Share (Annual)$1.35

Price vs S&P 500 (13W)-55.46%

Beta6.24x

Revenue / Share (TTM)$1.34

ROE (TTM)-351.28%

52-Week Low$0.26

vGradeA

gGradeB

mGradeF

vgmGradeC

VVOS Earnings Surprise History

Q2 25-0.55est. -0.38

Q3 25-0.49est. -0.51

Q4 25-0.58est. -0.48

Q1 26-0.52est. -0.45

Q2 26-0.31est. -0.39

VVOS Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
VVOSVivos Therapeutics, Inc. Common Stock	A	B	F	$0.27
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics develops a non-invasive oral appliance system for treating mild-to-moderate obstructive sleep apnea, combining customized devices with proprietary clinical protocols. The approach offers patients a lower-cost alternative to surgery or pharmaceuticals. The therapy is delivered through a network of specially trained dentists working with medical professionals, creating a differentiated market position in sleep disorder treatment.